Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × relatlimab × Clear all

Sponsor

Conditions

Melanoma 4 Advanced Cancer 3 Uveal Melanoma 2 Recurrence 2 Lymphoma, Non-Hodgkin 2 Various Advanced Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Advanced Gastric Cancer 1

Interventions

vandetanib 7 Sorafenib 6 Magnetic Resonance Spectroscopy 6 lenvatinib 5 cabozantinib 5 Sunitinib 4 Iodine-131 4 selpercatinib 3 AZD 6244 3 trametinib 2 tipifarnib 2 durvalumab 2 dabrafenib 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Thyrotropin Alfa 2 Paclitaxel 2 Nivolumab 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 Everolimus 2 Bortezomib 2 Axitinib 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 tremelimumab 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡